Meropenem

Related Experiment Video

Updated: Aug 12, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Dheeraj Shah1, Manish Narang

  • 1Department of Pediatrics, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi 110 095, India. shahdheeraj@hotmail.com

Indian Pediatrics
|June 1, 2005
PubMed

Insights

Meropenem is a broad-spectrum carbapenem antibiotic effective against many bacteria, including in severe pediatric infections like meningitis. Reserve its use for difficult cases to prevent resistance.

Area of Science:

  • Pharmacology
  • Microbiology
  • Pediatrics

Background:

  • Meropenem is a carbapenem antibiotic with broad-spectrum activity.
  • It exhibits stability against common bacterial beta-lactamases.

Purpose of the Study:

  • To evaluate the utility of meropenem in treating severe pediatric infections.
  • To assess its efficacy in meningitis and infections in neutropenic children.

Main Methods:

  • Clinical data review of meropenem use in hospitalized children.
  • Assessment of meropenem's pharmacokinetic profile, including CSF penetration.

Main Results:

  • Meropenem demonstrated efficacy in severe gram-negative, gram-positive, and anaerobic infections.
  • Good cerebrospinal fluid (CSF) penetration supports its use in childhood meningitis.

Conclusions:

  • Meropenem is highly useful for severe pediatric infections, particularly meningitis and in neutropenic children.
  • Due to resistance concerns, it should be reserved for difficult-to-treat infections or treatment failures.

More Related Videos

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Published on: May 12, 2023

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...